Abstract
Continuous positive airway pressure (CPAP) is currently the most effective treatment for obstructive sleep apnea (OSA) and is considered the “gold standard” for patient care. The most common indications for treatment are excessive daytime sleepiness, disruption in sleep quality, and reduction in overall quality of life. In addition, CPAP is used to treat OSA-related cognitive impairment and depressed mood. In a number of chronic medical conditions such as hypertension, type 2 diabetes mellitus, and coronary artery disease, OSA is considered an independent risk factor for their development. Use of CPAP may be indicated in these conditions to prevent their development or mitigate their severity. Treatment success with CPAP can be defined on the basis of both subjective improvement in symptoms and objective evidence of adherence to therapy. Current definitions of adequate adherence to CPAP treatment may be somewhat arbitrary. For individual patients, both subjective and objective data should be used to conclude whether CPAP treatment has been successful.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- AF:
-
Atrial fibrillation
- AHI:
-
Apnea-hypopnea index
- APAP:
-
Auto-adjusting continuous positive airway pressure
- ASV:
-
Adaptive servo ventilation
- BP:
-
Blood pressure
- BPAP:
-
Bi-level positive airway pressure
- CAD:
-
Coronary artery disease
- CHF:
-
Congestive heart failure
- CMS:
-
Centers for Medicare and Medicaid Services
- CPAP:
-
Continuous positive airway pressure
- CVD:
-
Cardiovascular disease
- ESS:
-
Epworth Sleepiness Scale
- FOSQ:
-
Functional Outcomes of Sleep Questionnaire
- LVEF:
-
Left ventricular ejection fraction
- OSA:
-
Obstructive sleep apnea
- QoL:
-
Quality of life
- SAQLI:
-
Sleep Apnea Quality of Life Index
- SF36:
-
Medical Outcomes Study Short-Form Health Survey
References
Sullivan CE, Berthon-Jones M, Issa FG, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862–5.
Guilleminault C, Simmons FB, Motta J, Cummiskey J, Rosekind M, Schroeder JS, et al. Obstructive sleep Apnea syndrome and tracheostomy: long-term follow-up experience. Arch Intern Med. 1981;141(8):985–8.
Zhu K, Roisman G, Aouf S, Escourrou SP. All APAPs are not equivalent for the treatment of sleep disordered breathing: a bench evaluation of eleven commercially available devices. J Clin Sleep Med. 2015;11(7):725–34.
Omobomi O, Quan SF. BPAP for CPAP failures: for the many or the few. Respirology. 2020;25(4):358–9.
Malfertheiner MV, Lerzer C, Kolb L, Heider K, Zeman F, Gfüllner F, et al. Whom are we treating with adaptive servo-ventilation? A clinical post hoc analysis. Clin Res Cardiol. 2017;106(9):702–10.
Salloum A, Rowley JA, Mateika JH, Chowdhuri S, Omran Q, Badr MS. Increased propensity for central apnea in patients with obstructive sleep apnea effect of nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2010;181(2):189–93.
Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006;29(3):375–80.
Budhiraja R, Kushida CA, Nichols DA, Walsh JK, Simon RD, Gottlieb DJ, et al. Predictors of sleepiness in obstructive sleep apnoea at baseline and after 6 months of continuous positive airway pressure therapy. Eur Respir J. 2017;50(5):1700348.
Krakow B, McIver ND, Ulibarri VA, Krakow J, Schrader RM. Prospective randomized controlled trial on the efficacy of continuous positive airway pressure and adaptive servo-ventilation in the treatment of chronic complex insomnia. EClinicalMedicine. 2019;13:57–73.
McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375(10):919–31.
Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep Apnea with positive airway pressure: an American Academy of sleep medicine systematic review, {meta-analysis}, and {GRADE} assessment. J Clin Sleep Med. 2019;15(2):301–34.
Wang M-L, Wang C, Tuo M, Yu Y, Wang L, Yu J-T, Tan L, Chi S. Cognitive effects of treating obstructive sleep Apnea: a meta-analysis of randomized controlled trials. J Alzheimers Dis. 2020; https://doi.org/10.3233/JAD-200088. Online ahead of print.
Kushida CA, Nichols DA, Holmes TH, Quan SF, Walsh JK, Gottlieb DJ, et al. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep Apnea patients: the Apnea positive pressure long-term efficacy study (APPLES). Sleep. 2012;35(12):1593–602. [published correction appears in Sleep. 2016 Jul 1;39(7):1483]
Richards KC, Gooneratne N, Dicicco B, Hanlon A, Moelter S, Onen F, et al. CPAP adherence may slow 1-year cognitive decline in older adults with mild cognitive impairment and Apnea. J Am Geriatr Soc. 2019;67(3):558–64.
Yamamoto H, Akashiba T, Kosaka N, Ito D, Horie T. Long-term effects nasal continuous positive airway pressure on daytime sleepiness, mood and traffic accidents in patients with obstructive sleep apnoea. Respir Med. 2000;94(1):87–90.
Bucks RS, Nanthakumar S, Starkstein SS, Hillman DR, James A, McArdle N, et al. Discerning depressive symptoms in patients with obstructive sleep apnea: the effect of continuous positive airway pressure therapy on Hamilton Depression Rating Scale symptoms. Sleep. 2018;41(12) https://doi.org/10.1093/sleep/zsy178.
Lewis EF, Wang R, Punjabi N, Gottlieb DJ, Quan SF, Bhatt DL, et al. Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: a Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis. Am Heart J. 2017;189:59–67.
Batool-Anwar S, Goodwin JL, Kushida CA, Walsh JA, Simon RD, Nichols DA, et al. Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA). J Sleep Res. 2016;25(6):731–8.
Campos-Rodriguez F, Queipo-Corona C, Carmona-Berna C, Jurado-Gamez B, Cordero-Guevara J, Reyes-Nuñez N, et al. Continuous positive airway pressure improves quality of life in women with obstructive sleep apnea a randomized controlled trial. Am J Respir Crit Care Med. 2016;194(10):1286–94.
Batool-Anwar S, Omobomi O, Quan S. The effect of CPAP on HRQOL as measured by the quality of Well-being self-administered questionnaire (QWB-SA). Southwest J Pulm Crit Care. 2020;20(1):29–40.
Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med. 2001;163(1):19–25.
Lee CH, Sethi R, Li R, Ho HH, Hein T, Jim MH, et al. Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention. Circulation. 2016;133(21):2008–17.
Mehra R. Sleep apnea and the heart. Cleve Clin J Med. 2019;86(9 Suppl 1):10–8.
Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi-Filho G. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176(7):706–12.
Nguyen PK, Katikireddy CK, McConnell MV, Kushida C, Yang PC. Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea. J Cardiovasc Magn Reson. 2010;12(1):50.
Hla KM, Young T, Hagen EW, Stein JH, Finn LA, Nieto FJ, et al. Coronary heart disease incidence in sleep disordered breathing: the Wisconsin sleep cohort study. Sleep. 2015;38(5):677–84.
Milleron O, Pillière R, Foucher A, De Roquefeuil F, Aegerter P, Jondeau G, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J. 2004;25(9):728–34.
Capodanno D, Milazzo G, Cumbo M, Marchese A, Salemi A, Quartarone L, et al. Positive airway pressure in patients with coronary artery disease and obstructive sleep apnea syndrome. J Cardiovasc Med. 2014;15(5):402–6.
Furlow B. SAVE trial: no cardiovascular benefits for CPAP in OSA. Lancet Respir Med. 2016;4(11):860.
Geovanini GR, Lorenzi-Filho G. Cardiac rhythm disorders in obstructive sleep apnea. J Thorac Dis. 2018;10(Suppl 34):S4221–30.
Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983;52(5):490–4.
Cadby G, McArdle N, Briffa T, Hillman DR, Simpson L, Knuiman M, et al. Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort. Chest. 2015;148(4):945–52.
Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation – results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015;169(5):647–654.e2.
Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62(4):300–5.
Caples SM, Mansukhani MP, Friedman PA, Somers VK. The impact of continuous positive airway pressure treatment on the recurrence of atrial fibrillation post cardioversion: a randomized controlled trial. Int J Cardiol. 2019;278:133–6.
Garrigue S, Pépin JL, Defaye P, Murgatroyd F, Poezevara Y, Clémenty J, et al. High prevalence of sleep apnea syndrome in patients with long-term pacing: the European multicenter polysomnographic study. Circulation. 2007;115(13):1703–9.
Wu X, Liu Z, Chang SC, Fu C, Li W, Jiang H, et al. Screening and managing obstructive sleep apnoea in nocturnal heart block patients: an observational study. Respir Res. 2016;17:16.
Lipford MC, Flemming KD, Calvin AD, Mandrekar J, Brown RD, Somers VK, et al. Associations between Cardioembolic stroke and obstructive sleep Apnea. Sleep. 2015;38(11):1699–705.
Dong R, Dong Z, Liu H, Shi F, Du J. Prevalence, risk factors, outcomes, and treatment of obstructive sleep Apnea in patients with cerebrovascular disease: a systematic review. J Stroke Cerebrovasc Dis. 2018;27(6):1471–80.
Bassetti CLA, Randerath W, Vignatelli L, Ferini-Strambi L, Brill AK, Bonsignore MR, et al. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. Eur J Neurol. 2020; https://doi.org/10.1111/ene.14201. Online ahead of print.
National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda: National Heart, Lung, and Blood Institute (US); 2004. https://www.ncbi.nlm.nih.gov/books/NBK9630/.
Javier Nieto F, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing sleep apnea, and hypertension in a large community-based study. J Am Med Assoc. 2000;283(14):1829–36.
De Oliveira AC, Martinez D, Massierer D, Gus M, Gonçalves SC, Ghizzoni F, et al. The antihypertensive effect of positive airway pressure on resistant hypertension of patients with obstructive sleep apnea: a randomized, double-blind, clinical trial. Am J Respir Crit Care Med. 2014;190(3):345–7.
Barbé F, Durán-Cantolla J, Capote F, De La Peña M, Chiner E, Masa JF, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;181(7):718–26.
Durán-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Terán-Santos J, Aguirregomoscorta JI, et al. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ. 2010;341:c5991.
Azarbarzin A, Sands SA, Taranto-Montemurro L, Vena D, Sofer T, Kim S-W, et al. The sleep apnea-specific hypoxic burden predicts incident heart failure. Chest. 2020;S0012-3692(20):30678–4.
Egea CJ, Aizpuru F, Pinto JA, Ayuela JM, Ballester E, Zamarrón C, et al. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Med. 2008;9(6):660–6.
Sommerfeld A, Althouse AD, Prince J, Atwood CW, Mulukutla SR, Hickey GW. Obstructive sleep apnea is associated with increased readmission in heart failure patients. Clin Cardiol. 2017;40(10):873–8.
Kamel G, Munzer K, Espiritu J. Use of CPAP in patients with obstructive sleep apnea admitted to the general ward: effect on length of stay and readmission rate. Sleep Breath. 2016;20(3):1103–10.
Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the sleep heart health study. Am J Epidemiol. 2004;160(6):521–30.
Reutrakul S, Mokhlesi B. Obstructive sleep Apnea and diabetes: a state of the art review. Chest. 2017;152(5):1070–86.
Shaw JE, Punjabi NM, Wilding JP, Alberti KGMM, Zimmet PZ. Sleep-disordered breathing and type 2 diabetes. A report from the international diabetes federation taskforce on epidemiology and prevention. Diabetes Res Clin Pract. 2008;81(1):2–12.
Adeseun GA, Rosas SE. The impact of obstructive sleep apnea on chronic kidney disease. Curr Hypertens Rep. 2010;12(5):378–83.
Choi HS, Kim HY, Han KD, Jung JH, Kim CS, Bae EH, et al. Obstructive sleep apnea as a risk factor for incident end stage renal disease: a nationwide population-based cohort study from Korea. Clin Exp Nephrol. 2019;23(12):1391–7.
Parajuli S, Tiwari R, Clark DF, Mandelbrot DA, Djamali A, Casey K. Sleep disorders: serious threats among kidney transplant recipients. Transplant Rev. 2019;33(1):9–16.
Li X, Liu C, Zhang H, Zhang J, Zhao M, Sun D, et al. Effect of 12-month nasal continuous positive airway pressure therapy for obstructive sleep apnea on progression of chronic kidney disease. Medicine (Baltimore). 2019;98(8):e14545.
Aron-Wisnewsky J, Clement K, Pépin JL. Nonalcoholic fatty liver disease and obstructive sleep apnea. Metabolism. 2016;65(8):1124–35.
Tamanna S, Campbell D, Warren R, Ullah MI. Effect of CPAP therapy on symptoms of nocturnal gastroesophageal reflux among patients with obstructive sleep apnea. J Clin Sleep Med. 2016;12(9):1257–61.
Johnson KG, Ziemba AM, Garb JL. Improvement in headaches with continuous positive airway pressure for obstructive sleep apnea: a retrospective analysis. Headache. 2013;53(2):333–43.
Arias MA, García-Río F, Alonso-Fernández A, Martínez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J. 2006;27(9):1106–13.
Chowdhuri S, Quan SF, Almeida F, Ayappa I, Batool-Anwar S, Budhiraja R, et al. An official American thoracic society research statement: impact of mild obstructive sleep apnea in adults. Am J Respir Crit Care Med. 2016;193(9):e37–54.
Badr MS, Toiber F, Skatrud JB, Dempsey J. Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol. 1995;78(5):1806–15.
Javaheri S, Smith J, Chung E. The prevalence and natural history of complex sleep apnea. J Clin Sleep Med. 2009;5(3):205–11.
Santamaria J, Iranzo A, Ma Montserrat J, de Pablo J. Persistent sleepiness in CPAP treated obstructive sleep apnea patients: evaluation and treatment. Sleep Med Rev. 2007;11(3):195–207.
Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest. 1993;103(6):1675–80.
Aurora RN, Collop NA, Jacobowitz O, Thomas SM, Quan SF, Aronsky AJ. Quality measures for the care of adult patients with obstructive sleep apnea. J Clin Sleep Med. 2015;11(3):357–83.
Reimer MA, Flemons WW. Quality of life in sleep disorders. Sleep Med Rev. 2003;7(4):335–49.
Silva G, Goodwin J, Vana K, Quan S. Obstructive sleep apnea and quality of life: comparison of the SAQLI, FOSQ, and SF-36 questionnaires. Southwest J Pulm Crit Care. 2016;13(3):137–49.
Kasibowska-Kuźniar K, Jankowska R, Kuźniar T, Brzecka A, Piesiak P, Zwierzycki J. Comparative evaluation of two health-related quality of life questionnaires in patients with sleep apnea. Wiad Lek. 2004;57(5–6):229–32.
Weaver TE, Mancini C, Maislin G, Cater J, Staley B, Landis JR, et al. Continuous positive airway pressure treatment of sleepy patients with milder obstructive sleep apnea: results of the CPAP apnea trial north american program (CATNAP) randomized clinical trial. Am J Respir Crit Care Med. 2012;186(7):677–83.
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–5.
Benbadis SR, Mascha E, Perry MC, Wolgamuth BR, Smolley LA, Dinner DS. Association between the Epworth sleepiness scale and the multiple sleep latency test in a clinical population. Ann Intern Med. 1999;130(4 Pt 1):289–92.
Quan SF. Abuse of the Epworth sleepiness scale. J Clin Sleep Med. 2013;9(10):987.
Gillberg M, Kecklund G, Akerstedt T. Relations between performance and subjective ratings of sleepiness during a night awake. Sleep. 1994;17(3):236–41.
Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10(4):431–6.
Schwab RJ, Badr SM, Epstein LJ, Gay PC, Gozal D, Kohler M, et al. An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems the optimal monitoring strategies and outcome measures in adults. Am J Respir Crit Care Med. 2013;188(5):613–20.
Berry RB, Kushida CA, Kryger MH, Soto-Calderon H, Staley B, Kuna ST. Respiratory event detection by a positive airway pressure device. Sleep. 2012;35(3):361–7.
Valentin A, Subramanian S, Quan SF, Berry RB, Parthasarathy S. Air leak is associated with poor adherence to autopap therapy. Sleep. 2011;34(6):801–6.
Rapoport DM. POINT: is the apnea-hypopnea index the best way to quantify the severity of sleep-disordered breathing? Yes Chest. 2016;149(1):14–6.
Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep. 2015;38(6):843–4.
Weaver TE, Maislin G, Dinges DF, Bloxham T, George CFP, Greenberg H, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007;30(6):711–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fashanu, O., Quan, S.F. (2022). When to Treat with CPAP and How to Define Success. In: Shapiro, C.M., Gupta, M., Zalai, D. (eds) CPAP Adherence. Springer, Cham. https://doi.org/10.1007/978-3-030-93146-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-93146-9_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-93144-5
Online ISBN: 978-3-030-93146-9
eBook Packages: MedicineMedicine (R0)